Curcumin Confers Anti-Inflammatory Effects in Adults Who Recovered from COVID-19 and Were Subsequently Vaccinated: A Randomized Controlled Trial.

“The results of the linear regression analyses revealed that assignment to the CURC group was associated with significantly lower mean post-trial concentrations of the inflammatory biomarkers, IL-6 (β = −0.52, 95% CI: −1.03,−0.014, p = 0.046) and MCP-1 (β = −0.12, 95% CI: −0.23, −0.015, p = 0.027) controlling for baseline and covariates, compared to the CON group (Table 2 and Table S2).”